Innovative ETFs ChannelWill Biotech ETFs Benefit from Biogen’s New Alzheimer’s Drug?By Ian YoungJune 9, 2021
Equity ETF ChannelBiotech ETFs Make Gains Tuesday, Despite the J&J Vaccine PauseBy Ian YoungApril 13, 2021
FeaturedModerna Helps Biotech ETFs Mitigate Massive Losses as Stocks TumbleBy Ian YoungJanuary 4, 2021
FeaturedAs U.K. Authorizes Pfizer Vaccine, Biotech ETFs Continue to RallyBy Ian YoungDecember 3, 2020
Nasdaq Portfolio Solutions ChannelA Junior Biotech ETF With Home Run PotentialBy Todd ShriberAugust 14, 2020
FeaturedBiotech ETFs Stable Despite Disappointing Treatment Date From GileadBy Ian YoungApril 23, 2020
Disruptive Technology Channel2 Biotechnology ETFs That Could Be Good For DiversificationBy Ian YoungMarch 26, 2020
Disruptive Technology ChannelA Biotech ETF at the Center of a Profit/Peril MarketBy Tom LydonFebruary 27, 2020
